Clinical and molecular insights into cardiovascular disease in psoriatic patients and the potential protective role of apremilast

Psoriatic disease, encompassing both psoriasis (Pso) and psoriatic arthritis (PsA), is closely intertwined with a significantly elevated risk of developing cardiovascular diseases. This connection is further compounded by a higher prevalence of cardiometabolic comorbidities, including type 2 diabete...

Full description

Bibliographic Details

Published in:	Frontiers in Immunology
Main Authors:	Nuria Barbarroja, Clementina López-Medina, Alejandro Escudero-Contreras, Iván Arias-de la Rosa
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-08-01
Subjects:	apremilast cardiometabolic comorbidities cardiovascular disease psoriatic arthritis psoriasis psoriatic disease
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1459185/full